1. Home
  2. |Insights
  3. |Pay-to-Play 2: CFIUS Filing Fees Go Into Effect May 1, 2020

Pay-to-Play 2: CFIUS Filing Fees Go Into Effect May 1, 2020

Client Alert | 1 min read | 04.28.20

The Committee on Foreign Investment in the US (CFIUS) has announced an Interim Final Rule requiring payment of filing fees in connection with any Joint Voluntary Notices submitted on or after May 1, 2020 for “covered transactions” under 31 C.F.R. Part 800 or for “covered real estate transactions” under Part 802. The Interim Final Rule adopts, without change, the sliding scale fee structure as initially proposed, but in light of the COVID-19 pandemic, will continue to accept comments until June 1, 2020.

The fee schedule is:

Total Transaction Value

Filing Fee

< $500,000

$0

> $500,000 but < $5 million

$750

> $5 million but < $50 million

$7,500

> $50 million but < $250 million

$75,000

> $250 million but < $750 million

$150,000

> $ 750 million

$300,000


CFIUS rejected comments seeking to limit the transaction value to just the value of the U.S. business and denied concerns that the lack of any fee for submission of mandatory or voluntary declarations would provide a financial or administrative incentive for CFIUS to fail to conclude action under Section 721 of the Defense Production Act in evaluating such declarations.

Contacts

Insights

Client Alert | 7 min read | 06.26.26

Federal Roundup: Updates for PBMs and Medicare Advantage Organizations

In June 2026, federal regulators and lawmakers continued their efforts to improve drug affordability through targeted reforms. These recent developments will primarily impact pharmaceutical manufacturers, managed care organizations, and pharmacy benefit managers (PBM) serving Medicare Part D program members. PBMs, Medicare Advantage organizations, and Part D sponsors should monitor these changes in the interest of maintaining compliance and providing input on regulatory proposals that may influence their business operations or compensation structures in the future....